CN Patent

CN102964349A — 苯并二氮杂*衍生物的托西酸盐及其多晶型、它们的制备方法和用途

Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2013-03-13 · 13y expired

What this patent protects

本发明涉及苯并二氮杂 衍生物的托西酸盐及其多晶型、它们的制备方法和用途，特别是3-[(4s)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑[1，2-a][1，4]苯并二氮杂 -4-基]丙酸甲酯(I)的托西酸盐多晶型及其制备方法和用途。本发明所得到的式(I)化合物托西酸盐的结晶，溶剂残留低，稳定性良好，可更好地用于临床治疗。

USPTO Abstract

本发明涉及苯并二氮杂 衍生物的托西酸盐及其多晶型、它们的制备方法和用途，特别是3-[(4s)-8-溴-1-甲基-6-(2-吡啶基)-4H-咪唑[1，2-a][1，4]苯并二氮杂 -4-基]丙酸甲酯(I)的托西酸盐多晶型及其制备方法和用途。本发明所得到的式(I)化合物托西酸盐的结晶，溶剂残留低，稳定性良好，可更好地用于临床治疗。

Drugs covered by this patent

Patent Metadata

Patent number
CN102964349A
Jurisdiction
CN
Classification
—
Expires
2013-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Jiangsu Hengrui Medicine Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.